Evaluation of the Efficacy of the Live Attenuated Tetravalent Dengue Vaccine Against DENV-2 and DENV-3 Challenge
Clinical trial NCT03416036 · COMPLETED
Trial details
- NCT number
- NCT03416036
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-28
- Primary completion
- 2019-01-17
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.